Back to top
more

Viemed Healthcare (VMD)

(Delayed Data from NSDQ)

$8.82 USD

8.82
294,109

-0.19 (-2.11%)

Updated Aug 28, 2026 04:00 PM ET

After-Market: $8.82 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth F Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 248)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Viemed Healthcare, Inc. (VMD) Misses Q1 Earnings Estimates

by Zacks Equity Research

Viemed Healthcare, Inc. (VMD) delivered earnings and revenue surprises of -42.86% and 3.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Pediatrix (MD) Down 4.2% Despite Q1 Earnings & Revenue Beat

by Zacks Equity Research

Investors are likely concerned about Pediatrix's (MD) lower enrollment in commercial insurance programs, escalating practice salaries and benefits and net borrowings.

Zacks Equity Research

BellRing Brands Inc. (BRBR) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

BellRing Brands (BRBR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

LeMaitre (LMAT) delivered earnings and revenue surprises of 8% and 7.63%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Viemed Healthcare, Inc. (VMD) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Viemed Healthcare, Inc. (VMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Equity Research

Elevance Health (ELV) Beats on Q1 Earnings, Hikes Profit View

by Zacks Equity Research

Elevance Health's (ELV) first-quarter results reflect growing premiums stemming from rate increases.

Zacks Equity Research

UnitedHealth (UNH) Beats on Q1 Earnings, Ups EPS 2023 View

by Zacks Equity Research

Strong membership growth and consistent management of medical and operating costs aid UnitedHealth's (UNH) UnitedHealthcare unit in the first quarter.

Zacks Equity Research

Viemed Healthcare, Inc. (VMD) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

If you are looking for stocks that are well positioned to maintain their recent uptrend, Viemed Healthcare, Inc. (VMD) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Zacks Equity Research

Brookdale (BKD) Q1 Adjusted EBITDA to Beat View, Occupancy Up

by Zacks Equity Research

Brookdale Senior Living (BKD) witnesses 17 straight months of year-over-year increases in weighted average occupancy level.

Zacks Equity Research

Palo Alto Networks and RH have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Palo Alto Networks and RH are part of the Zacks Bull and Bear of the Day article.